2023 - Bringing Clinical Trial Access to Underserved Populations in a Community Setting
Date2023-05-23
Deadline2023-05-23
VenueWebinar, USA - United States
KeywordsClinical Trial Access; Patient Diversity; Clinical Trial Diversity
Topics/Call fo Papers
Clinical trials are an important healthcare option, presenting benefits to patients, physicians and the broader community. Yet, relatively low enrollment rates have continued to be a bottleneck for clinical trials. In traditional research settings, about four percent of the US population has participated in a trial, of which only six percent represent Black and Latinx populations, even though those groups make up nearly 30 percent of the US population. Innovative and scalable solutions that are industry compliant are needed to make equity a reality, thus bringing clinical trial access to underserved populations.
This webinar will provide an opportunity to discover a model that provides clinical trial access to previously under-represented and underserved populations while removing barriers and unlocking doors to innovation. Imagine a trial that adjusts to patients’ schedules, travel capabilities and daily life obligations.
Join featured speakers from PPD and EmVenio Research as they lead a discussion of how localization — learning and adapting to a community’s local language, culture and traditions — has and can increase trial awareness, and clinical trial access to patients everywhere, making equity a reality, leading to an improved patient experience.
Register now to join the discussion on increasing study enrollment, enabling greater diversity and thinking differently about engaging underserved populations.
This webinar will provide an opportunity to discover a model that provides clinical trial access to previously under-represented and underserved populations while removing barriers and unlocking doors to innovation. Imagine a trial that adjusts to patients’ schedules, travel capabilities and daily life obligations.
Join featured speakers from PPD and EmVenio Research as they lead a discussion of how localization — learning and adapting to a community’s local language, culture and traditions — has and can increase trial awareness, and clinical trial access to patients everywhere, making equity a reality, leading to an improved patient experience.
Register now to join the discussion on increasing study enrollment, enabling greater diversity and thinking differently about engaging underserved populations.
Other CFPs
- Antibody Reduction in Bioprocessing: Analytical Detection and Steps for Mitigation
- Digital Endpoint Development for Alzheimer’s Disease: The Importance of Patients as Partners
- CNS and Chronic Drug Trials: New Cardiac Safety Requirements
- Using Digital Pathology to Accelerate Preclinical R&D
- Anti-Idiotypic Antibody Platforms for Accelerating Antibody Drug Discovery
Last modified: 2023-05-09 06:03:42